FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to neurology, and can be used for treating patients with focal form of mixed encephalitis-borreliosis infection in acute period. For this purpose at background of etiotropic and pathogenetic therapy intravenous introduction of normal human immunoglobulin is made in daily dose of 2.5 g in course of 3-5 days, inclusive, regardless of day of disease.
EFFECT: method allows reducing risk of residual neurological deficiency due to formation of own active specific immunity at low probability of protein overload.
1 cl, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF DEVELOPING MIXED TICK-BORNE ENCEPHALITIS AND BORRELIOSIS INFECTION | 2011 |
|
RU2456603C1 |
| METHOD OF PREDICTING SEVERITY OF COURSE OF TICK-BORNE INFECTIOUS DISEASES | 2008 |
|
RU2376938C1 |
| COMPLEX METHOD FOR TREATING THE PATIENTS SUFFERING FROM RUSSIAN TICK-BORNE ENCEPHALITIS | 1998 |
|
RU2158606C2 |
| METHOD OF TREATMENT OF PATIENTS WITH TICK-BORNE ENCEPHALITIS | 1999 |
|
RU2167671C2 |
| METHOD OF TREATING TICK-BORNE ENCEPHALITIS | 2011 |
|
RU2473364C2 |
| METHOD FOR ASSESSMENT OF FOCAL TICK-BORNE ENCEPHALITIS PATIENT CONDITION SEVERITY | 2007 |
|
RU2347523C2 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF INFECTIOUS ENCEPHALITIS IN CHILDREN | 2023 |
|
RU2824592C1 |
| METHOD OF LEUKOENCEPHALITIS TREATMENT IN CHILDREN | 2007 |
|
RU2348411C2 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF FOCAL FORM OF TICK-BORNE ENCEPHALITIS | 2003 |
|
RU2240046C1 |
| METHOD FOR PREDICTING RESULTS OF TICKBORNE ENCEPHALITIS | 2000 |
|
RU2202789C2 |
